SynXT Therapeutics
The science of better health
H. Fan et al., Assessment of Phenylboronic Acid Nitrogen Mustards as Potent and Selective Drug Candidates for Triple-Negative Breast Cancer. ACS Pharmacol Transl Sci 4, 687-702 (2021).
Ali, T et al. Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment. Cancers 2024, 16, 2171.
Ali, T et al. Exploiting Vitamin C as a Prooxidant to Activate Ros-Responsive Prodrugs for Potent and Selective Tumor Killing. Available at SSRN: http://dx.doi.org/10.2139/ssrn.5096518
SynXT Therapeutics 